Madhav Dhodapkar | Professor
Emory University

Madhav Dhodapkar, Professor, Emory University

Dr Madhav Dhodapkar is the director of Winship Center for Cancer Immunology, Anise McDaniel Brock Chair, Georgia Research Alliance Eminent Scholar in Cancer Innovation and professor of Hematology and Medical Oncology in the Emory School of Medicine. He also co-leads the cancer immunology program at Winship Cancer Institute. Prior to moving to Emory in 2018, Dhodapkar served as chief of hematology, the Arthur H. and Isabel Bunker Professor of Medicine (Hematology), and professor of immunobiology at Yale University School of Medicine. An expert in cancer immunology, he also was co-director of the Cancer Immunology Program within the Yale Cancer Center. Dr Dhodapkar’s research focuses on how the immune system regulates the progression from precursor lesions to cancer as well as the mechanisms of treatment sensitivity and resistance to cancer immunotherapy and biology of dendritic cells.

Dr Dhodapkar earned his medical degree from the All India Institute of Medical Sciences in New Delhi, India, and completed his fellowship in oncology at the Mayo Clinic in Rochester, Minnesota. Prior to Yale, Dhodapkar served on the faculty at Memorial Sloan Kettering Cancer Center and The Rockefeller University in New York. He is a prior recipient of several awards including the NIH Director’s Transformative Research Award and the NCI Outstanding Investigator Award.


Day 2, April 8 @ 16:40

Panel: 2020-2030 insights and expectations for the next decade of cancer vaccine development

  • Session goals: Dr Karolina Palucka, The Jackson Laboratory
  • 4:40 – 5:40: Antigens and adjuvants
  • 5:40 – 6.10: Clinical settings
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates